PL353444A1 - Dawki miesięczne do leczenia zakażesigma Streptococcus pneumoniae - Google Patents

Dawki miesięczne do leczenia zakażesigma Streptococcus pneumoniae

Info

Publication number
PL353444A1
PL353444A1 PL00353444A PL35344400A PL353444A1 PL 353444 A1 PL353444 A1 PL 353444A1 PL 00353444 A PL00353444 A PL 00353444A PL 35344400 A PL35344400 A PL 35344400A PL 353444 A1 PL353444 A1 PL 353444A1
Authority
PL
Poland
Prior art keywords
treatment
streptococcus pneumoniae
glycopeptide antibiotics
pneumoniae infections
monthly doses
Prior art date
Application number
PL00353444A
Other languages
English (en)
Inventor
Thomas Reeves Parr
Margaret Mary Wasilewski
Michael Lee Zeckel
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL353444A1 publication Critical patent/PL353444A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL00353444A 1999-05-03 2000-04-19 Dawki miesięczne do leczenia zakażesigma Streptococcus pneumoniae PL353444A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03
PCT/US2000/008737 WO2000066144A2 (en) 1999-05-03 2000-04-19 Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumoniae infections

Publications (1)

Publication Number Publication Date
PL353444A1 true PL353444A1 (pl) 2003-11-17

Family

ID=22453188

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353444A PL353444A1 (pl) 1999-05-03 2000-04-19 Dawki miesięczne do leczenia zakażesigma Streptococcus pneumoniae

Country Status (29)

Country Link
EP (1) EP1175222B1 (pl)
JP (1) JP2002543146A (pl)
KR (1) KR100757165B1 (pl)
CN (1) CN1349407A (pl)
AR (1) AR023827A1 (pl)
AT (1) ATE284702T1 (pl)
AU (1) AU774647B2 (pl)
BR (1) BR0010244A (pl)
CA (1) CA2372790A1 (pl)
CZ (1) CZ296127B6 (pl)
DE (1) DE60016734T2 (pl)
DZ (1) DZ3039A1 (pl)
EA (1) EA004295B1 (pl)
HK (1) HK1044707B (pl)
HR (1) HRP20010808A2 (pl)
HU (1) HUP0200940A3 (pl)
IL (2) IL145582A0 (pl)
MY (1) MY123542A (pl)
NO (1) NO20015291L (pl)
NZ (1) NZ514467A (pl)
PE (1) PE20010292A1 (pl)
PL (1) PL353444A1 (pl)
SK (1) SK285970B6 (pl)
SV (1) SV2002000065A (pl)
TR (1) TR200103211T2 (pl)
TW (1) TWI255716B (pl)
UA (1) UA73937C2 (pl)
WO (1) WO2000066144A2 (pl)
ZA (1) ZA200108013B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2297830C1 (ru) * 2005-09-27 2007-04-27 Леонид Федосеевич Ляпустин Способ лечения воспалительных заболеваний легких
PT3006038T (pt) * 2008-08-30 2024-08-23 The Medicines Co Doses únicas de oritavancina para tratamento ou prevenção de uma infeção bacteriana
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
KR102237887B1 (ko) 2013-03-15 2021-04-07 멜린타 서브시디어리 코프. 항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
LT3038616T (lt) * 2013-08-26 2023-05-25 Melinta Therapeutics, Inc. Bakteriemijos ir osteomielito gydymo būdai naudojant oritavanciną

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
EP1175222A2 (en) 2002-01-30
WO2000066144A2 (en) 2000-11-09
DZ3039A1 (fr) 2004-03-27
CZ296127B6 (cs) 2006-01-11
TR200103211T2 (tr) 2002-02-21
HK1044707B (en) 2005-09-30
MY123542A (en) 2006-05-31
CN1349407A (zh) 2002-05-15
HUP0200940A3 (en) 2002-10-28
EA200101171A1 (ru) 2002-04-25
ZA200108013B (en) 2003-03-26
TWI255716B (en) 2006-06-01
SK285970B6 (sk) 2007-12-06
SK15572001A3 (sk) 2003-05-02
PE20010292A1 (es) 2001-03-07
UA73937C2 (en) 2005-10-17
CA2372790A1 (en) 2000-11-09
KR100757165B1 (ko) 2007-09-07
SV2002000065A (es) 2002-12-02
AU774647B2 (en) 2004-07-01
HUP0200940A2 (en) 2002-08-28
AU4329200A (en) 2000-11-17
JP2002543146A (ja) 2002-12-17
ATE284702T1 (de) 2005-01-15
IL145582A (en) 2008-12-29
NO20015291L (no) 2001-12-17
DE60016734T2 (de) 2005-12-08
BR0010244A (pt) 2002-01-08
IL145582A0 (en) 2002-06-30
AR023827A1 (es) 2002-09-04
EP1175222B1 (en) 2004-12-15
WO2000066144A3 (en) 2001-04-12
NZ514467A (en) 2005-01-28
KR20020008173A (ko) 2002-01-29
HRP20010808A2 (en) 2002-12-31
EA004295B1 (ru) 2004-02-26
DE60016734D1 (de) 2005-01-20
CZ20013949A3 (cs) 2002-07-17
HK1044707A1 (en) 2002-11-01
NO20015291D0 (no) 2001-10-29

Similar Documents

Publication Publication Date Title
IL148641A0 (en) Topical treatment of streptococcal infections
HUS1500040I1 (hu) Sztreptokokkusz oltóanyag
EP1162994A4 (en) COMPOSITION FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF STREPTOCOCCAL INFECTIONS
AU4054900A (en) Desleucyl glycopeptide antibiotics and methods of making same
AU1727702A (en) Macrolide antibiotics
HU9802525D0 (en) Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
IL144178A0 (en) Ketolide antibiotics
AU5029700A (en) Glycopeptide antibacterial compounds, compositions containing same and methods of using same
PL353444A1 (pl) Dawki miesięczne do leczenia zakażesigma Streptococcus pneumoniae
AU7882600A (en) Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity
AU2001257163A1 (en) Glycopeptide antibacterial compounds and methods of using same
AU2001269239A1 (en) Use of c4-c10 acids for preventing gram-negative bacterial infections
HUP0003409A3 (en) Use of macrolide antibiotics for the prepartion of pharmaceutical compositions treating or preventing coccidiosis
DE60023158D1 (en) Phagenresistentes streptococcus thermophilus
ZA991410B (en) Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
AU4145999A (en) Topical drug for the treatment of viral infections
AU3355095A (en) Diagnostic drug for chlamydia infection
AU2002336752A1 (en) Composition for treating streptococcus pneumoniae
AU5493500A (en) Antibody-based treatment for streptococcus pneumoniae infection
AU1540501A (en) Streptococcus pneumoniae antigens
NO991827D0 (no) FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon
AU1673200A (en) Medicaments for the treatment of lung infections
GB2362827B (en) Pharmaceutical preparation for treating viral infections
AU4706799A (en) Treatment of (staphylococcus) infections
HK1047543A (en) Topical treatment of streptococcal infections

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed